Tricyclic heterocycle derivatives having HIV replication inhibitory effect

US9975906B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9975906-B2
Application numberUS-201515311757-A
CountryUS
Kind codeB2
Filing dateMay 15, 2015
Priority dateMay 16, 2014
Publication dateMay 22, 2018
Grant dateMay 22, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides the following compound having anti-HIV activity of formula: wherein, A 1 is C, CR 1A or N; A 2 is C, CR 2A , or N; A 3 is CR 3A , CR 3A R 3B , N, NR 3C , O, S, SO, or SO 2 ; A 4 is CR 4A , CR 4A R 4B , N, NR 4C , O, S, SO, or SO2; A 5 is C, CR 5A , or N; T 1 ring is substituted or unsubstituted monocyclic carbocycle or substituted or unsubstituted monocyclic heterocycle; R 1 is halogen, cyano, nitro or —X 1 —R 11 ; R 2 is substituted or unsubstituted alkyl and the like; n is 1 or 2; R 3 is hydrogen, substituted or unsubstituted aromatic carbocyclyl; R 4 is hydrogen or a carboxy protecting group; the other symbols are as specified in the description.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein A 1 is C, CR 1A , or N; A 2 is C, CR 2A , or N; A 3 is CR 3A , CR 3A R 3B , N, NR 3C , O, S, SO, or SO 2 ; A 4 is CR 4A , CR 4A R 4B , N, NR 4C , O, S, SO, or SO 2 ; A 5 is C, CR 5A , or N; A 6 is C, CR 6A , or N; R 1A , R 2A , R 3A , R 3B , R 4A , R 4B , R 5A , and R 6A are each independently hydrogen, halogen, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkyl oxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted alkyl carbonyl, substituted or unsubstituted alkenyl carbonyl, substituted or unsubstituted alkynyl carbonyl, substituted or unsubstituted aromatic carbocyclyl, substituted or unsubstituted non-aromatic carbocyclyl, substituted or unsubstituted aromatic heterocyclyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted aromatic carbocycle oxy, substituted or unsubstituted non-aromatic carbocycle oxy, substituted or unsubstituted aromatic heterocycle oxy, substituted or unsubstituted non-aromatic heterocycle oxy, substituted or unsubstituted aromatic carbocycle thio, substituted or unsubstituted non-aromatic carbocycle thio, substituted or unsubstituted aromatic heterocycle thio, substituted or unsubstituted non-aromatic heterocycle thio, substituted or unsubstituted aromatic carbocycle amino, substituted or unsubstituted non-aromatic carbocycle amino, substituted or unsubstituted aromatic heterocycle amino, substituted or unsubstituted non-aromatic heterocycle amino, substituted or unsubstituted aromatic carbocyclylcarbonyl, substituted or unsubstituted non-aromatic carbocyclylcarbonyl, substituted or unsubstituted aromatic heterocyclylcarbonyl, substituted or unsubstituted non-aromatic heterocyclylcarbonyl, substituted or unsubstituted aromatic carbocyclylalkylcarbonyl, substituted or unsubstituted non-aromatic carbocyclylalkylcarbonyl, substituted or unsubstituted aromatic heterocyclylalkyl carbonyl, substituted or unsubstituted non-aromatic heterocyclylalkylcarbonyl, substituted or unsubstituted amino, or substituted or unsubstituted carbamoyl; R 3C and R 4C are each independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkyl oxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted aromatic carbocyclyl, substituted or unsubstituted non-aromatic carbocyclyl, substituted or unsubstituted aromatic heterocyclyl, or substituted or unsubstituted non-aromatic heterocyclyl; or, R 3A and R 3B may be taken together to form oxo, R 4A and R 4B may be taken together to form oxo; R 3A and R 4A may be taken together with an adjacent atom to form substituted or unsubstituted monocyclic carbocycle, or substituted or unsubstituted monocyclic heterocycle, the carbocycle or heterocycle may be further fused to; R 3A and R 4C may be taken together with an adjacent atom to form substituted or unsubstituted monocyclic heterocycle, the heterocycle may be further fused to; R 3C and R 4A may be taken together with an adjacent atom to form substituted or unsubstituted monocyclic heterocycle, the heterocycle may be further fused to; R 3C and R 4C may be taken together with an adjacent atom to form substituted or unsubstituted monocyclic heterocycle, the heterocycle may be further fused to; R 3A and R 3B may be taken together with an adjacent atom to form substituted or unsubstituted spiro ring, the spiro ring may be further fused to; R 4A and R 4B may be taken together with an adjacent atom to form substituted or unsubstituted spiro ring, the spiro ring may be further fused to; R 4B may be taken together with an atom on the circular arc of T 1 ring to form substituted or unsubstituted monocyclic carbocycle, or substituted or unsubstituted monocyclic heterocycle, the carbocycle or heterocycle may be further fused to; R 4C may be taken together with an atom on the circular arc of T1 ring to form substituted or unsubstituted monocyclic heterocycle, the heterocycle may be further fused to; the broken line means the presence or absence of bond, the adjacent broken lines do not exist at the same time, the carbon atoms on 1st, 2nd, and 3rd position are sp 2 carbon; T 1 ring is substituted or unsubstituted monocyclic carbocycle or substituted or unsubstituted monocyclic heterocycle, (1) the carbocycle or heterocycle may be fused with the other substituted or unsubstituted carbocycle or substituted or unsubstituted heterocycle, and/or (2) two atoms which are not adjacent to one another constituting the carbocycle or heterocycle may be bridged by substituted or unsubstituted alkylene, substituted or unsubstituted alkenylene or substituted or unsubstituted alkynylene; R 1 is halogen, cyano, nitro or —X 1 —R 11 , X 1 is a bond, —O—, —S—, —NR 12 —, —CO—, —SO—, —SO 2 —O—CO—, —CO—O—, —NR 12 —CO—, —CO—NR 12 —, —NR 12 —CO—O—, —NR 12 —CO—NR 13 , —NR 12 —SO 2 — or —SO 2 —NR 12 —, R 11 is hydrogen atom, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted carbocyclyl, or substituted or unsubstituted heterocyclyl, R 12 and R 13 are each independently hydrogen atom, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl or substituted or unsubstituted alkynyl, when X 1 is —NR 12 —, —CO—NR 12 or —SO 2 —NR 12 —, R 11 and R 12 may be taken together with an adjacent nitrogen atom to form substituted or unsubstituted heterocyclyl, X 1 is —NR 12 —CO—NR 13 —, R 11 and R 13 may be taken together with an adjacent nitrogen atom to form substituted or unsubstituted heterocyclyl, R 1 may be taken together with a carbon atom or a nitrogen atom on the circular arc of T 1 ring to form substituted or unsubstituted monocyclic carbocycle, or substituted or unsubstituted monocyclic heterocycle, the carbocycle or heterocycle may be further fused to; R 2 is each substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkyloxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted cycloalkyloxy, or substituted or unsubstituted cycloalkenyloxy; n is 1 or 2; R 3 is substituted or unsubstituted aromatic carbocyclyl, substituted or unsubstituted non-aromatic carbocyclyl, substituted or unsubstituted aromatic heterocyclyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted aromatic carbocycle alkenyl, substituted or unsubstituted non-aromatic carbocycle alkenyl, substituted or unsubstituted aromatic heterocycle alkenyl, substituted or unsubstituted non-aromatic heterocycle alkenyl, substituted or unsubstituted aromatic carbocycle alkynyl, substituted or unsubstituted non-aromatic carbocycle alkynyl, substituted or unsubstituted aromatic heterocycle alkynyl, or substituted or unsubstituted non-aromatic heterocycle alkynyl; and R 4 is hydrogen or a carboxy protecting group. 2. The compound or pharmaceutically acceptable salt thereof according to claim 1 , wherein the formula (I) is one of formulas (I-A), (I-B) and (I-C):

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9975906B2 cover?
The present invention provides the following compound having anti-HIV activity of formula: wherein, A 1 is C, CR 1A or N; A 2 is C, CR 2A , or N; A 3 is CR 3A , CR 3A R 3B , N, NR 3C , O, S, SO, or SO 2 ; A 4 is CR 4A , CR 4A R 4B , N, NR 4C , O, S, SO, or SO2; A 5 is C, CR 5A , or N; T 1 ring is substituted or unsubstituted monocyclic carbocycle o…
Who is the assignee on this patent?
Shionogi & Co
What technology area does this patent fall under?
Primary CPC classification C07D513/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).